Remote ischemic conditioning (RIC) in ischemic stroke: functional validation of conditioned plasma in human cells
Year: 2022
Type: dissertation
Abstract: Stroke is the first cause of death and disability in Portugal and the second worldwide. The available therapeutic approaches to stroke treatment, thrombolysis, and mechanical thrombectomy promote blood reperfusion but do not directly target the brain parenchyma. Remote ischemic conditioning (RIC) is a specific sub-type of conditioning that triggers our endogenous mechanisms of defense through the application of a stimulus, below the damage threshold, such as ischemia. In this particular case, a non-vital organ (arm) is submitted to 4 cycles of 5 minutes ischemia followed by 5 minutes reperfusion, the RIC procedure, which may stimulate protective signaling to remote target organs (such as the brain). In this light, our objective was to understand the humoral mechanisms underlying the neuroprotective effects of this procedure, in particular whether and how RIC-conditioned plasma affected neuroinflammation, neuronal function, and blood-brain barrier integrity. We found that RIC-derived plasma promoted significant anti-inflammatory results since it limits reactive oxygen species generation when human HMC3 microglial cells are challenged with LPS and ATP inflammatory treatment. Therefore, indicating that one of the possible ways for RIC-induced protection occurs via inhibition of ROS production. Additionally, RIC-conditioned plasma also exhibited neuroprotective properties, by increasing synaptophysin expression, a marker for neuronal activity. These results reinforce the protective role of the RIC procedure. Lastly, slight BBB protective effects were also observed after treating the human brain microvasculature endothelial cells hCMEC/D3 cell line with RIC-derived plasma. However, these results should be further validated. All in all, besides demonstrating the possible beneficial effects of the RIC procedure, this work also showed a novel way to study these effects, which can be a stepping stone for future studies and the possible clinical application of this novel therapy.
Author: Pires, Catarina Cardoso
Institution: Universidade Nova de Lisboa
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7024232866
